Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-26 @ 5:34 AM
Study NCT ID:
NCT00846560
Status:
WITHDRAWN
Last Update Posted:
2017-10-11
First Post:
2009-02-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)
Sponsor:
Rambam Health Care Campus
Organization:
Study Overview
Official Title:
Involvement of Lymphocyte Type B in Amyotrophic Lateral Sclerosis (ALS)
Status:
WITHDRAWN
Status Verified Date:
2017-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Changes in the lab's focus and needs
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The involvement of Lymphocyte type B in Amyotrophic lateral sclerosis (ALS) patients will be compared to lymphocyte in healthy subjects.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: